Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells. Read more about Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells.
Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Read more about Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population.
Estrogen metabolizing polymorphisms and breast cancer risk among older white women. Read more about Estrogen metabolizing polymorphisms and breast cancer risk among older white women.
Immune dysfunction and micrometastases in women with breast cancer. Read more about Immune dysfunction and micrometastases in women with breast cancer.
A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer. Read more about A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer.
Development of a novel method for measuring in vivo breast epithelial cell proliferation in humans. Read more about Development of a novel method for measuring in vivo breast epithelial cell proliferation in humans.
Insulin-like growth factor (IGF)-system mRNA quantities in normal and tumor breast tissue of women with sporadic and familial breast cancer risk. Read more about Insulin-like growth factor (IGF)-system mRNA quantities in normal and tumor breast tissue of women with sporadic and familial breast cancer risk.
Mammography surveillance following breast cancer. Read more about Mammography surveillance following breast cancer.
Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole. Read more about Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole.
Reducing disparities in breast cancer survival: a Columbia University and Avon Breast Cancer Research and Care Network Symposium. Read more about Reducing disparities in breast cancer survival: a Columbia University and Avon Breast Cancer Research and Care Network Symposium.
